The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment Stefan Baral, MD, Amrita Rao, ScM, Patrick.

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 373, Issue 9659, Pages (January 2009)

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

Volume 2, Issue 5, Pages (May 2015)

Volume 355, Issue 9221, Pages (June 2000)

Cautious optimism on public health in post-earthquake Haiti

Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study Dr Brian G Williams, PhD, Somya Gupta, MA,

The Lancet Public Health

Volume 2, Issue 4, Pages e151-e158 (April 2015)

HIV Prevention 2020: a framework for delivery and a call for action

Meta-analysis of randomised controlled trials

Volume 13, Issue 12, Pages (December 2012)

HIV-positive women's experiences of a PMTCT programme in rural Malawi

Volume 5, Issue 4, Pages e181-e189 (April 2018)

Volume 4, Issue 10, Pages e457-e464 (October 2017)

Political factors behind US global AIDS programmes slow-down

Volume 376, Issue 9743, (September 2010)

Volume 379, Issue 9816, Pages (February 2012)

Volume 9, Issue 9, Pages (September 2008)

WHO's new guidelines for antiretroviral treatment

Health-system performance

Future challenges for clinical care of an ageing population infected with HIV: a modelling study Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,

Exploring the heart of the human heart

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Gene therapy—where are we?

Volume 4, Issue 1, Pages e31-e40 (January 2017)

The Gobi Desert medical kit

Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an.

Physiological hazards of flight at high altitude

Prevention of HIV spread during the Ebola outbreak in Guinea

Can famine relief meet health and hunger goals simultaneously?

Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study Dr Brian G Williams, PhD, Somya Gupta, MA,

Can plagues be predicted, prevented?

Disease and stigma The Lancet Volume 354, (December 1999)

Volume 3, Issue 12, Pages e592-e600 (December 2016)

Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study Nabihah Sachedina, MBBS, Prof.

HIV myths should not be resuscitated

Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis Ulla Beijer, PhD, Achim Wolf, MSc, Dr.

Volume 5, Issue 8, Pages e417-e426 (August 2018)

James E Scriven, David G Lalloo, Graeme Meintjes

Volume 379, Issue 9821, Pages (March 2012)

Volume 381, Issue 9875, Pages (April 2013)

Volume 384, Issue 9944, Pages (August 2014)

Low-level lead exposure and mortality in US adults: a population-based cohort study Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,

A voracious creature The Lancet Volume 358, (December 2001)

Economic opportunity, health behaviours, and health outcomes in the USA: a population-based cross-sectional study Dr Atheendar S Venkataramani, MD, Rachel.

Volume 13, Issue 12, Pages (December 2012)

Volume 9, Issue 1, Pages (January 2012)

What would happen if we stopped vaccination?

Disparities in mortality among 25–44-year-olds in England: a longitudinal, population- based study Prof Evangelos Kontopantelis, PhD, Prof Iain Buchan,

Volume 9, Issue 9, Pages (September 2008)

Reproductive health for refugees

Volume 375, Issue 9709, Pages (January 2010)

Volume 392, Issue 10144, Pages (July 2018)

Infant-feeding patterns and HIV-1 transmission

Prevention of HIV spread during the Ebola outbreak in Guinea

Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD The Lancet

Volume 375, Issue 9722, Pages (April 2010)

Volume 377, Issue 9777, Pages (May 2011)

Volume 376, Issue 9734, Pages (July 2010)

Volume 373, Issue 9672, Pages (April 2009)

Costs of eliminating HIV in South Africa have been underestimated

Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people.

Children and adolescents with HIV

The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study

Volume 6, Issue 6, Pages e382-e395 (June 2019)

Political factors behind US global AIDS programmes slow-down

Oldest and most feared disease

Volume 6, Issue 7, Pages (July 2019)

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study Gayatri Amirthalingam,

Presentation transcript:

The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment Stefan Baral, MD, Amrita Rao, ScM, Patrick Sullivan, PhD, Nancy Phaswana-Mafuya, PhD, Daouda Diouf, MS, Greg Millett, MPH, Helgar Musyoki, MPH, Elvin Geng, MD, Sharmistha Mishra, PhD The Lancet HIV DOI: 10.1016/S2352-3018(19)30226-7 Copyright © 2019 Elsevier Ltd Terms and Conditions

Figure 1 Experimental studies evaluating HIV treatment outcomes at the population level and individual level Details of studies and comparisons are given in the main text. Blue lines represent studies with population-level outcomes and red lines are studies with individual-level outcomes. aHR=adjusted hazard ratio. aRR=risk ratio. IRR=incidence rate ratio. ART=antiretroviral therapy. The Lancet HIV DOI: (10.1016/S2352-3018(19)30226-7) Copyright © 2019 Elsevier Ltd Terms and Conditions

Figure 2 Numbers of new HIV infections and HIV treatment coverage in Botswana, Rwanda, and Ethiopia 2010–17 ART=antiretroviral therapy. The Lancet HIV DOI: (10.1016/S2352-3018(19)30226-7) Copyright © 2019 Elsevier Ltd Terms and Conditions